EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Giant cell arteritis in Finland from 2010 to 2020: incidence, developing diagnostic methods and disease presentation

Lauri Kivitalo iD, Kirsi Taimen iD, Tuulikki Sokka-Isler iD, Anne Kerola iD, Joonas Rautavaara iD, Laura Pirilä iD, Markku Kauppi iD, Joel Malila iD, Laura Haara, Laura Ryyppö iD, Taina Kotijärvi iD, Panu Saarenketo iD und 5 weitere

Rheumatology Advances in Practice · 14.03.2025 · 9 (2)

DOI: 10.1093/rap/rkaf055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology Advances in Practice, online erschienen am 15.05.2025. Verfasst von Lauri Kivitalo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tampere University Hospital Support Foundation, Tampere University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To study the annual incidence, diagnostic methods used and clinical presentation of giant cell arteritis (GCA) over time in Finland.

Methods

Newly diagnosed GCA patients from 2010 to 2020 were retrospectively identified from four healthcare districts in Finland. Medical records were reviewed and data on incidence, diagnostic methods, phenotype [cranial vs large vessel (LV)-GCA] and clinical presentation were analysed.

Results

We identified 602 newly diagnosed GCA patients. The annual incidence was 9.0 cases/100 000 persons (95% CI 8.3, 9.7) ≥50 years of age and was significantly higher in the period 2016–2020 compared with the period 2010–2015 [11.3 (95% CI 10.1, 12.5) vs 7.0 (95% CI 6.2, 7.9), P < 0.001]. Imaging- or biopsy-confirmed diagnosis was recorded in 75% of GCA patients, while 25% had a clinical diagnosis. The proportion of imaging- or biopsy-confirmed diagnoses increased over time [64.7% (2010–2015) vs 82.2% (2016–2020)] while that of clinical diagnoses decreased. The use of imaging methods increased while the use of temporal artery biopsies decreased between the two time periods. LV-GCA was discovered more often in the period 2016–2020 when compared with 2010–2015 (34.0% vs 19.3% of patients).

Conclusion

The incidence of GCA increased during the study period, as well as the proportion of imaging- or biopsy-confirmed diagnoses, probably due to more frequent use of advanced imaging methods. Additionally, patients with LV-GCA were more commonly identified.

Schlagwörter

Stichwörter der Autor:innen

biopsydiagnosisgiant cell arteritisincidencephenotypeultrasoundvasculitis

Autor:innen und Institutionen

  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Department of Internal Medicine, Seinäjoki Central Hospital, Wellbeing Services County of South Ostrobothnia, Seinäjoki, Finland.
  • Centre for Rheumatology and Clinical Immunology, Department of Medicine, Turku University Hospital, Turku, Finland.
  • Faculty of Medicine, University of Turku, Turku, Finland.
  • Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
  • Unit of Rheumatology, Hospital Nova, Wellbeing Services County of Central Finland, Jyväskylä, Finland.

ORCID-Profile: Lauri Kivitalo, Kirsi Taimen, Tuulikki Sokka-Isler, Anne Kerola, Joonas Rautavaara, Laura Pirilä, Markku Kauppi, Joel Malila, Laura Ryyppö, Taina Kotijärvi, Panu Saarenketo, Hannu Saarivaara, Juho Siltanen, Mika Helminen, Jarno Rutanen, Pia Isomäki

Förderung

  • Tampere University Hospital Support Foundation
  • Tampere University Hospital

Zitieren

APA

Kivitalo, L., Taimen, K., Sokka-Isler, T., Kerola, A., Rautavaara, J., Pirilä, L., Kauppi, M., Malila, J., Haara, L., Ryyppö, L., Kotijärvi, T., Saarenketo, P., Saarivaara, H., Siltanen, J., Helminen, M., Rutanen, J., & Isomäki, P. (2025). Giant cell arteritis in Finland from 2010 to 2020: incidence, developing diagnostic methods and disease presentation. Rheumatology Advances in Practice, 9(2). https://doi.org/10.1093/rap/rkaf055

Vancouver

Kivitalo L, Taimen K, Sokka-Isler T, Kerola A, Rautavaara J, Pirilä L, et al. Giant cell arteritis in Finland from 2010 to 2020: incidence, developing diagnostic methods and disease presentation. Rheumatology Advances in Practice. 2025;9(2). doi:10.1093/rap/rkaf055

BibTeX
@article{Kivitalo2025,
  author = {Kivitalo, Lauri and Taimen, Kirsi and Sokka-Isler, Tuulikki and Kerola, Anne and Rautavaara, Joonas and Pirilä, Laura and Kauppi, Markku and Malila, Joel and Haara, Laura and Ryyppö, Laura and Kotijärvi, Taina and Saarenketo, Panu and Saarivaara, Hannu and Siltanen, Juho and Helminen, Mika and Rutanen, Jarno and Isomäki, Pia},
  title = {Giant cell arteritis in Finland from 2010 to 2020: incidence, developing diagnostic methods and disease presentation},
  journal = {Rheumatology Advances in Practice},
  year = {2025},
  volume = {9},
  number = {2},
  doi = {10.1093/rap/rkaf055}
}
Kostenlos starten →